Indeed, the most interesting result was related to the evidence that GBM cells, along with tumor progression, showed the upregulation of genes, such as interferon regulatory factor 8 (IRF-8) and chemokines belonging to the myeloid population, regardless of gene mutations and clonal selections. This evidence concerns the gene IRF8 and glioblastoma.